|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Guardant Health, Inc. (GH) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
121,380,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0 - $0 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Guardant Health is a precision oncology company focused on helping conquer cancer globally through use of its proprietary blood-based tests, data sets and analytics. Co. is engaged in the clinical liquid biopsy market with its Guardant360 and GuardantOMNI tests. Co.'s Guardant360 test is a molecular diagnostic test measuring a number of cancer-related genes and its GuardantOMNI test has a 500-gene panel, both of which analyze circulating tumor DNA in blood. In addition, Co. is developing tests from its LUNAR-1 program for minimal residual disease and recurrence detection in cancer survivors, and its LUNAR-2 program for early detection of cancer.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
2,187 |
2,187 |
98,220 |
| Total Buy Value |
$0 |
$38,963 |
$38,963 |
$2,585,297 |
| Total People Bought |
0 |
1 |
1 |
2 |
| Total Buy Transactions |
0 |
1 |
1 |
4 |
| Total Shares Sold |
100 |
200 |
8,325 |
31,716 |
| Total Sell Value |
$2,787 |
$4,692 |
$233,035 |
$1,293,892 |
| Total People Sold |
1 |
1 |
2 |
3 |
| Total Sell Transactions |
1 |
2 |
6 |
12 |
| End Date |
2024-03-28 |
2023-12-26 |
2023-06-27 |
2022-06-27 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Talasaz Amirali |
Chairman, President and COO |
• • – |
2019-04-23 |
4 |
AS |
$66.17 |
$1,112,583 |
D/D |
(16,607) |
2,438 |
|
- |
|
| Talasaz Amirali |
Chairman, President and COO |
• • – |
2019-04-23 |
4 |
OE |
$4.18 |
$63,544 |
D/D |
15,202 |
19,045 |
|
- |
|
| Talasaz Amirali |
Chairman, President and COO |
• • – |
2019-04-23 |
4 |
AS |
$66.06 |
$4,216,868 |
I/I |
(62,937) |
18,399 |
|
- |
|
| Eltoukhy Helmy |
Chief Executive Officer |
• • – |
2019-04-22 |
4 |
AS |
$64.20 |
$5,875,617 |
I/I |
(90,000) |
43,780 |
|
- |
|
| Talasaz Amirali |
Chairman, President and COO |
• • – |
2019-04-22 |
4 |
AS |
$63.91 |
$3,183,897 |
D/D |
(48,532) |
3,843 |
|
- |
|
| Talasaz Amirali |
Chairman, President and COO |
• • – |
2019-04-22 |
4 |
OE |
$4.18 |
$185,701 |
D/D |
44,426 |
52,375 |
|
- |
|
| Talasaz Amirali |
Chairman, President and COO |
• • – |
2019-04-22 |
4 |
AS |
$63.89 |
$12,066,016 |
I/I |
(183,928) |
29,005 |
|
- |
|
| Wiley Michael J |
Chief Legal Officer |
• – – |
2019-04-18 |
4 |
AS |
$68.93 |
$6,280,883 |
D/D |
(90,000) |
345,358 |
|
- |
|
| Jallal Bahija |
Director |
– • – |
2019-04-17 |
4 |
A |
$0.00 |
$0 |
D/D |
2,837 |
2,837 |
|
- |
|
| Lanman Richard B. |
Chief Medical Officer |
• – – |
2019-04-17 |
4 |
AS |
$71.66 |
$3,338,724 |
D/D |
(46,244) |
130,631 |
|
- |
|
| Lanman Richard B. |
Chief Medical Officer |
• – – |
2019-04-17 |
4 |
OE |
$1.43 |
$165,709 |
D/D |
46,244 |
176,875 |
|
- |
|
| Lanman Richard B. |
Chief Medical Officer |
• – – |
2019-04-16 |
4 |
AS |
$76.56 |
$3,445,200 |
D/D |
(45,000) |
130,631 |
|
- |
|
| Lanman Richard B. |
Chief Medical Officer |
• – – |
2019-04-16 |
4 |
OE |
$1.43 |
$64,350 |
D/D |
45,000 |
175,631 |
|
- |
|
| Clark Ian T |
Director |
– • – |
2019-04-15 |
4 |
AS |
$73.90 |
$6,042,951 |
D/D |
(81,772) |
0 |
|
- |
|
| Clark Ian T |
Director |
– • – |
2019-04-15 |
4 |
OE |
$4.18 |
$341,807 |
D/D |
81,772 |
81,722 |
|
- |
|
| Lanman Richard B. |
Chief Medical Officer |
• – – |
2019-04-15 |
4 |
AS |
$73.98 |
$3,357,045 |
D/D |
(45,000) |
130,631 |
|
- |
|
| Lanman Richard B. |
Chief Medical Officer |
• – – |
2019-04-15 |
4 |
OE |
$1.43 |
$64,350 |
D/D |
45,000 |
175,631 |
|
- |
|
| Sb Investment Advisers (uk) Ltd |
10% Owner |
– – • |
2019-03-12 |
4/A |
B |
$9.83 |
$20,000,020 |
D/D |
2,033,990 |
27,850,460 |
2.45 |
- |
|
| Wiley Michael J |
Chief Legal Officer |
• – – |
2019-03-12 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,000 |
435,358 |
|
- |
|
| Sb Investment Advisers (uk) Ltd |
10% Owner |
– – • |
2019-03-12 |
4 |
B |
$9.83 |
$19,999,817 |
D/D |
2,033,990 |
27,850,420 |
2.45 |
- |
|
| Temasek Holdings Ltd |
10% Owner |
– – • |
2018-10-09 |
4 |
A |
$0.00 |
$0 |
I/I |
1,613,007 |
596,012 |
|
- |
|
| Sb Investment Advisers (uk) Ltd |
10% Owner |
– – • |
2018-10-09 |
4 |
A |
$0.00 |
$0 |
D/D |
25,816,470 |
25,816,470 |
|
- |
|
| Softbank Corp |
10% Owner |
– – • |
2018-10-09 |
4 |
A |
$0.00 |
$0 |
D/D |
2,033,990 |
2,033,990 |
|
- |
|
| Talasaz Amirali |
Chairman, President and COO |
• • – |
2018-10-09 |
4 |
A |
$0.00 |
$0 |
I/I |
21,937 |
4,153,631 |
|
- |
|
| Wiley Michael J |
Chief Legal Officer |
• – – |
2018-10-09 |
4 |
A |
$0.00 |
$0 |
D/D |
6,561 |
439,949 |
|
- |
|
707 Records found
|
|
Page 28 of 29 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
